|Content Release Date: 2/8/2023
Expiration Date: 7/1/2024
CE Credits: There is NO CE ASSOCIATED WITH THIS ACTIVITY.
Activity Fee: Free
This presentation will highlight expert guidance for optimizing treatment and prevention of COVID-19 in the immunocompromised as well as strategies for reaching the target population.
Engaging the Experts Podcasts
|CE Credits: none||CE Credits: none|
This activity was planned to meet the educational needs of pharmacists who want to optimize treatment and prevention of COVID-19 in the immunocompromised population.
After participating in this CPE activity, learners should be able to:
ACPE Number: 0204-0000-22-423-H01-P
- Describe the pharmacist’s role in prevention and treatment strategies for immunocompromised patients at risk for COVID-19 infection
- Discuss the role of pre-exposure prophylaxis in an immunocompromised patient
- Create a treatment plan for an immunocompromised patient with COVID-19 infection
- Summarize prevention and management strategies for COVID-19 in immunocompromised pediatric patients
Katherine Yang, PharmD, MPH, FCSHP
Health Sciences Clinical Professor of Pharmacy
University of California, San Francisco (UCSF) School of Pharmacy
Infectious Diseases Clinical Pharmacist
UCSF Medical Center
San Francisco, California
Monica V. Mahoney PharmD, BCPS, BCIDP, FCCP
Clinical Pharmacy Specialist, Infectious Diseases
Outpatient ID/OPAT Clinics
Beth Israel Deaconess Medical Center
Senior Director, Pharmacy Practice and Quality
Sarah Parsons, PharmD, BCPPS
Clinical Pharmacy Specialist Pediatric Infectious Diseases
Antimicrobial Stewardship, Cystic Fibrosis
The Children's Hospital of the King's Daughters
Provided by ASHP
Supported by an educational grant from AstraZeneca Inc.